Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population

NCT05837884 is registered in ClinicalTrials.gov with Tel-Aviv Sourasky Medical Center as lead sponsor.

NCT NCT05837884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05837884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population
Lead sponsor
Tel-Aviv Sourasky Medical Center
Phase
Observational
Overall status
Recruiting
Start date
September 5, 2023
Completion date
June 30, 2029
Enrollment
2,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

healthy